Novo Nordisk stock rises after Wegovy recommended by UK’s drug price regulator

Written by

in

Michael Siluk | UCG | Universal Images Group | Getty Images

Novo Nordisk rose as much as 4% after England’s drug price watchdog recommended the use of its best-selling drug Wegovy to prevent heart attacks and strokes, marking the first GLP-1…

Continue Reading

News Source: www.cnbc.com

Comments

Leave a Reply Cancel reply

More posts